KRT17 and bladder transitional cell carcinoma: There was no difference in KRT17 expression between tumor and normal tissues in bladder urothelial carcinoma (BLCA), kidney renal papillary cell carcinoma (KIRP), and pancreatic adenocarcinoma (PAAD) (p > 0.05).